FDA Inspection 888857 — Bracco Diagnostics, Inc.

Bracco Diagnostics, Inc. — FEI 1000307800

The FDA completed an inspection of Bracco Diagnostics, Inc. on May 30, 2014 in Princeton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 30, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Princeton, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
1781321 CFR 212.50(a)Written control procedures
673021 CFR 314.80(b)Failure to develop written procedures

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.